The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
暂无分享,去创建一个
H. Walter | R. Kaiser | T. Berg | M. Däumer | F. Wiesmann | P. Braun | R. Ehret | M. Stürmer | H. Knechten | G. Naeth | J. Vachta | A. Tappe